Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial
Incyte Corporation
Laurie H Sehn; Kai Hübel; Stefano Luminari; Christian W Scholz; Antonio Salar; Shankara Paneesha; Björn Engelbrekt Wahlin; Panayiotis Panayiotidis; Hui-Peng Lee; Ana Jiménez-Ubieto; Juan-Manuel Sancho; Tae Min Kim; Eva Domingo Domenech; Takahiro Kumode; Christina Poh; Catherine Thieblemont; Dries Deeren; Edwin de Wit; Michael Arbushites; Irene Vassallo; Marek Trneny; inMIND Study team